This page is available in multiple languages

Select Language

04/06/2018

Playing this video will load a content from YouTube, a service of Google LLC. For information on how Google may use your data, see the Google privacy policy.

Accept cookies

Kiadis Pharma sounds the gong in Amsterdam

Kiadis Pharma (ticker symbol: KDS), received this year’s tech 40 label from Euronext. Companies with the Tech 40 label are young technology companies listed on Euronext markets and operating in life sciences, eco-industries or TMT. An independent group of European experts selected the first 40 on the basis of their business, financial and stock market performance.

Kiadis Pharma is a clinical stage biopharmaceutical company focused on research, development and future commercialisation of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders.

For more information: www.kiadis.com

Download photo